AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.92 and traded as high as $4.80. AIkido Pharma shares last traded at $4.32, with a volume of 197,919 shares.
AIkido Pharma Stock Performance
The business’s fifty day moving average price is $5.20 and its two-hundred day moving average price is $2.93. The stock has a market capitalization of $22.65 million, a P/E ratio of -1.06 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Further Reading
- Five stocks we like better than AIkido Pharma
- What is MarketRank™? How to Use it
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- 3 Small Caps With Big Return Potential
- 3 ETFs to Ride the VIX Surge During Market Volatility
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
